Evidence map›Paper›PMID 25377191›Full record

ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2015

Platelet-rich plasma for open meniscal repair in young patients: any benefit?

Nicolas Pujol, Etienne Salle De Chou, Philippe Boisrenoult, Philippe Beaufils

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02872753 (Intra-operative ACP Injection Following Partial Meniscectomy), which is not on this map. Cited by 58 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02872753 phase4completednot on this mapstarted 2017, after this paper: background citation

Intra-operative ACP Injection Following Partial Meniscectomy: a Randomized Controlled Trial

TypeinterventionalSponsorIstituto Ortopedico RizzoliRan2017 to 2023Enrolled90ConditionsMeniscectomyArmsACP, Standard Meniscectomy
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Biological augmentation of meniscal repair: a systematic review.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2022
    Pooled it
  4. Platelet-rich plasma (PRP) augmentation does not result in more favourable outcomes in arthroscopic meniscal repair: a meta-analysis.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2022
    Pooled it
  5. Pooled it
  6. The repair of horizontal cleavage tears yields higher complication rates compared to meniscectomy: a systematic review.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2020
    Pooled it
  7. Pooled it
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Management of Horizontal Cleavage Meniscus Tears.Current reviews in musculoskeletal medicine · 2025
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Platelet-rich plasma and other injectables in the young athlete.Journal of the Pediatric Orthopaedic Society of North America · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicolas PujolOrthopedic Department, Centre Hospitalier de Versailles, Versailles-Saint Quentin University, 177, rue de Versailles, 78157, Le Chesnay, France, npujol@ch-versailles.fr.
Etienne Salle De Chou
Philippe Boisrenoult
Philippe Beaufils

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMany studies have demonstrated that injection of various growth factors including platelet-derived growth factor could increase meniscal cell activity and stimulate repair. The purpose of this study was to augment repair and promote meniscal healing by the use of platelet-rich plasma (PRP) within horizontal cleavage meniscal tears repaired via an open approach. The hypothesis was that the clinical outcomes and healing process would be improved using this meniscal healing augmentation technique.

methodsIn this case-control study, 34 consecutive young patients underwent an open meniscal repair to treat symptomatic Grade 2 or Grade 3 horizontal meniscal tears [median age 28 years (13-40)]. The median time between the onset of symptoms and surgery was 11.5 months (6-50). In the first group (17 consecutive patients, Group 1), a standard open meniscal repair was performed. In the second group (17 consecutive patients, Group 2), the same surgical repair was performed, but platelet-rich plasma was introduced into the lesion at the end of the procedure. Clinical outcomes were evaluated using KOOS and IKDC 2000 scores. MRI was performed at 1 year after surgery for objective evaluation.

resultsAt a minimum of 24 months postoperatively (mean 32.2 months, 24-40), three patients underwent subsequent meniscectomy (two in Group 1, one in Group 2). The mean KOOS distribution (pain, symptoms, daily activities, sports, quality of life) was 78.4, 86.1, 93.8, 74.4, 74.6 in Group 1, and 93.3, 90.7, 97.1, 88.8, 78.3 in Group 2 (p < 0.05 for pain and sports parameters). MRI revealed five cases with the complete disappearance of any hypersignal within the repaired meniscus in Group 2, and none in Group 1 (p < 0.01).

conclusionsOpen meniscal repair of horizontal tears extending into the avascular zone was effective at midterm follow-up in young patients. Clinical outcomes were slightly improved by the addition of PRP in this case-control study. LEVEL OF EVIDENCE: III.

Indexed as

Platelet-Rich PlasmaAdolescentAdultArthroscopyCase-Control StudiesFemaleHumansKnee InjuriesMagnetic Resonance ImagingMaleMenisci, TibialQuality of LifeTibial Meniscus InjuriesTreatment OutcomeWound HealingYoung Adult

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.